A new condom, designed by the Australian bio-technic firm Starpharma, to kill the HIV virus could be available to buy within months after it received vital approval. The product has now received a receipt of Conformity of Assessment Certification by the Australian Therapeutic Goods Administration - a similar certificate to the CE mark in Europe - paving the way for mass production.It means the condom, the first of its kind, should be available to buy in the coming months.
The condoms are lubricated with VivaGel, which contains 0.5 per cent astodrimer sodium - a non-antibiotic, antimicrobial drug designed specifically as a compound against HIV. It is hoped the gel will help reduce the transmission of HIV and other STIs, while also reducing the risk of pregnancy.It is being produced by Australian bio-tech firm Starpharma in partnership with another firm called Ansell, which is responsible…
